Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma
Clinical trial NCT06341712 · TERMINATED
Trial details
- NCT number
- NCT06341712
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-22
- Primary completion
- 2026-02-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.